Effect of novel anti-tumor and anti-angiogenesis drug taurolactone on angiogenic factor AGGF1 and angiogenesis mimicry in patients with hepatocellular carcinoma. This evidence concerns the gene AGGF1 and hepatocellular carcinoma.